A new model for collaboration--making emergency contraceptives available in developing countries.

Area of Science:

• Public health
• Reproductive health
• Pharmaceutical research

Background:

• Emergency contraception (EC) has been available since the 1970s but remains under-utilized globally.
• EC serves a specific purpose for women seeking to prevent pregnancy in particular situations.
• Limited access and awareness contribute to the under-utilization of EC in developing countries.

Purpose of the Study:

• To explore the benefits of public-private sector collaboration for emergency contraception (EC) research and development.
• To propose a holistic approach for increasing EC availability in developing countries through partnerships.
• To highlight the mutual advantages of collaboration between public and private entities in advancing EC initiatives.

Main Methods:

• The paper reviews existing literature and case studies on public-private partnerships in pharmaceutical development.
• It analyzes the specific contributions and reciprocal benefits of collaboration between a public consortium and a private pharmaceutical company.
• The focus is on strategic approaches for introducing and expanding EC access.

Main Results:

• Public-private collaborations offer distinct advantages for both sectors in the context of EC.
• Partnerships can streamline research, development, and distribution processes for EC.
• A collaborative approach fosters mutual interests, leading to progress in EC accessibility.

Conclusions:

• Public-private partnerships are crucial for overcoming barriers to emergency contraception (EC) access in developing countries.
• A collaborative strategy ensures that the interests of both public health and commercial entities are met.
• This approach is essential for advancing the availability and utilization of EC globally.